Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8(+) T cell depletion.

Frank C, Allen KJH, Dawicki W, Levin MC, Dadachova E

Open source

DOI
10.3389/fmed.2025.1593933
Published
2025
Container
Frontiers in medicine
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fmed.2025.1593933,
  title = {Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8(+) T cell depletion.},
  author = {Frank C and Allen KJH and Dawicki W and Levin MC and Dadachova E},
  year = {2025},
  journal = {Frontiers in medicine},
  doi = {10.3389/fmed.2025.1593933},
  url = {https://doi.org/10.3389/fmed.2025.1593933}
}

RIS

TY  - JOUR
TI  - Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8(+) T cell depletion.
AU  - Frank C
AU  - Allen KJH
AU  - Dawicki W
AU  - Levin MC
AU  - Dadachova E
PY  - 2025
JO  - Frontiers in medicine
DO  - 10.3389/fmed.2025.1593933
UR  - https://doi.org/10.3389/fmed.2025.1593933
ER  - 

APA

C, F., KJH, A., W, D., MC, L., & E, D. (2025). Fingolimod synergizes with anti-PD-1 radioimmunotherapy in an experimental multiple sclerosis model through enhanced lymph node retention and CD8(+) T cell depletion.. Frontiers in medicine. https://doi.org/10.3389/fmed.2025.1593933

Source records